Trials / Not Yet Recruiting
Not Yet RecruitingNCT07146100
Long-term Follow-up Study to Evaluate Participants With Chronic Hepatitis B (CHB) Previously Treated With AHB-137 Injection
Prospective, Open-label, Multicenter Long-term Follow-up Study to Evaluate the Durability of Virologic Response in Participants With Chronic Hepatitis B Previously Treated With AHB-137 Injection
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Ausper Biopharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is a prospective, open-label, multicenter long-term follow-up study to evaluate the durability of virologic response in subjects with chronic hepatitis B previously treated with AHB-137 injection.
Conditions
Timeline
- Start date
- 2025-08-21
- Primary completion
- 2028-01-01
- Completion
- 2030-01-01
- First posted
- 2025-08-28
- Last updated
- 2025-08-28
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07146100. Inclusion in this directory is not an endorsement.